free encyclopedia|NN jump|NN navigation|NN jump|NN search|NN Multiple sclerosis|Disease name|NN Multiple sclerosis|Disease Multiple sclerosis|Disease Multiple sclerosis|Disease tissue|NN show macrophage|NN area|NN demyelinate lesion|NN cause Multiple sclerosis|Disease
neurology symptom|NN double vision|NN blindness|NN eye|NN muscle|NN weakness|NN trouble|NN sensation|NN trouble|NN coordination|NN usual onset|NN age|NN duration|NN long term|NN cause|NN unknown diagnostic method|NN base symptom|NN medical test|NN treatment|NN physical therapy|NN year|NN shorter life|NN expectancy|NN frequency|NN death|NN
Multiple sclerosis|Disease Multiple sclerosis|Disease demyelinate disease|NN insulate cover|NN nerve|NN cell|NN brain|NN spinal cord|NN damage damage|NN disrupt ability|NN part|NN nervous system|NN communicate result range|NN sign|NN symptom|NN physical mental sometime psychiatric problem|NN specific symptom|NN include double vision|NN blindness|NN eye|NN muscle|NN weakness|NN trouble|NN sensation|NN coordination|NN Multiple sclerosis|Disease take form|NN new symptom|NN occure isolate attack|NN relapse form|NN build time|NN progressive form|NN attack|NN symptom|NN disappear completely permanent neurological problem|NN remain especially advancement|NN disease|NN
cause|NN unclear underly mechanism|NN thought destruction|NN immune system|NN failure|NN myelin-produce cell|NN propose cause|NN include genetics|NN environmental factor|NN trigger viral infection|NN Multiple sclerosis|Disease usually diagnose base present|NN sign|NN symptom|NN result|NN support medical test|NN
known cure|NN Multiple sclerosis|Disease treatment|NN attempt improve function|NN attack|NN prevent new attack|NN use treat Multiple sclerosis|Disease modestly effective side|NN effect|NN poorly tolerate physical therapy|NN help people|NN ability|NN function people|NN pursue alternative treatment|NN lack|NN evidence|NN benefit|NN long-term outcome|NN difficult predict good outcome|NN seen women|NN develop disease|NN early life|NN relapse course|NN initially experience attack|NN life|NN expectancy|NN average|NN year|NN lower unaffect population|NN
Multiple sclerosis|Disease common immune-mediate|NN disorder|NN affect central nervous system|NN people|NN affect globally rate|NN vary widely different region|NN different population|NN year|NN people|NN dy Multiple sclerosis|Disease 12000|NN disease|NN usually begin age|NN twice common women|NN men|NN Multiple sclerosis|Disease describe name|NN Multiple sclerosis|Disease refer numerous scar|NN known plaque|NN lesion|NN develop white matter|NN brain|NN spinal cord|NN number|NN new treatment|NN diagnostic method|NN development|NN Multiple sclerosis|Disease webmplay media|NN video|NN summary|NN script|NN content|NN
sign|NN symptom|NN cause|NN geography|NN genetics|NN infectious agent|NN barrier|NN diagnosis|NN type|NN management|NN acute attack|NN treatment|NN associate symptom|NN alternative treatment|NN epidemiology|NN history|NN medical discovery|NN diagnosis|NN historical case|NN research|NN disease|NN chronic cerebrospinal venous insufficiency|NN see reference|NN external link|NN
sign|NN symptom|NN main article|NN Multiple sclerosis|Disease sign|NN symptom|NN main symptom|NN Multiple sclerosis|Disease
person|NN Multiple sclerosis|Disease neurological symptom|NN sign|NN autonomic visual motor|NN sensory problem|NN common specific symptom|NN determine location|NN lesion|NN nervous system|NN include loss|NN sensitivity|NN change|NN sensation|NN tingle pin|NN needle|NN numbness|NN muscle|NN weakness|NN blure vision|NN pronounce reflexe|NN muscle|NN spasm|NN difficulty|NN move difficulty|NN coordination|NN balance|NN problem|NN speech|NN swallow visual problem|NN optic|NN double vision|NN feel|NN tire acute chronic pain|NN bladder|NN bowel|NN difficulty|NN difficulty|NN think|NN emotional problem|NN depression|NN unstable mood|NN common uhthoff|NN phenomenon|NN worsen|NN symptom|NN due exposure|NN higher usual temperature|NN sign|NN electrical sensation|NN run back|NN bend neck|NN particularly characteristic Multiple sclerosis|Disease main measure|NN disability|NN severity|NN expand disability|NN status|NN scale|NN measure|NN Multiple sclerosis|Disease functional composite increasingly use research|NN
condition|NN begin case|NN clinically isolate syndrome|NN cis|NN number|NN day|NN motor|NN sensory problem|NN optic|NN symptom|NN relate brainstem|NN dysfunction|NN remain previous difficulty|NN course|NN symptom|NN occur main pattern|NN initially episode|NN sudden worsen|NN last day|NN month|NN call relapse|NN bout|NN attack|NN flare-up|NN follow improvement|NN case|NN gradual worsen|NN time|NN period|NN recovery|NN 1015|NN case|NN combination|NN pattern|NN occur people|NN start relapse|NN course|NN become progressive later relapse|NN usually predictable occure warn|NN rarely occur frequently twice year|NN relapse|NN precede common trigger|NN occur frequently spring|NN summer|NN similarly viral infection|NN common cold influenza|NN gastroenteritis|NN increase|NN risk|NN stress|NN trigger attack|NN women|NN Multiple sclerosis|Disease become pregnant experience|NN relapse|NN month|NN delivery|NN risk|NN increase overal pregnancy|NN seem influence long-term disability|NN event|NN found affect relapse|NN rate|NN vaccination|NN breast|NN feed physical trauma|NN phenomenon|NN cause|NN
cause|NN Multiple sclerosis|Disease unknown believe occur result|NN combination|NN genetic environmental factor|NN infectious agent|NN theory|NN try combine data|NN likely explanation|NN prove definitive
number|NN environmental risk|NN factor|NN partly modifiable further research|NN need determine elimination|NN prevent Multiple sclerosis|Disease geography|NN
Multiple sclerosis|Disease common people|NN live farther equator|NN exception|NN exist exception|NN include ethnic group|NN low risk|NN far equator|NN samis|NN canadian|NN new|NP zealand|NP m|NP
inuit|NN well group|NN relatively high risk|NN close equator|NN inland sicilian|NN palestinian|NN parsy cause|NN geographical pattern|NN clear north-south|NN gradient|NN incidence|NN decrease present
Multiple sclerosis|Disease common region|NN northern european population|NN geographic variation|NN simply reflect global distribution|NN high-risk population|NN sunlight|NN exposure|NN result decrease vitamin|NN d|NP production|NN put forward explanation|NN relationship|NN season|NN birth|NN Multiple sclerosis|Disease lend support|NN idea|NN people|NN born northern hemisphere|NN november|NP compare affect later life|NN environmental factor|NN play role|NN childhood|NN study|NN find people|NN move different region|NN world|NN age|NN acquire new region|NN risk|NN Multiple sclerosis|Disease
migration|NN take place|NN age|NN person|NN retain risk|NN home|NN country|NN evidence|NN effect|NN move|NN apply people|NN older genetics|NN hla|NP region|NN
change|NN area|NN increase|NN probability|NN get Multiple sclerosis|Disease
Multiple sclerosis|Disease consider hereditary disease|NN number|NN genetic variation|NN show increase risk|NN gene|NN appear higher level|NN expression|NN microglial cell|NN expect chance|NN probability|NN develop disease|NN higher relative|NN affect person|NN greater risk|NN closely relate identical twin|NN affect time|NN twin|NN sible|NN affect lower percentage|NN half-sible|NN parent|NN affect risk|NN children|NN time|NN general population|NN Multiple sclerosis|Disease common ethnic group|NN
specific gene|NN link Multiple sclerosis|Disease include difference|NN human leukocyte|NN antigen|NN hla|NP systema|NP group|NN gene|NN chromosome|NN serve major histocompatibility|NN complex|NN mhc|NP difference|NN hla|NP region|NN relate susceptibility|NN known region|NN implicate development|NN autoimmune|NN disease|NN diabete|NN type|NN systemic lupus|NN consistent find|NN association|NN Multiple sclerosis|Disease allele|NN mhc|NP define dr15|NN locy|NN show protective effect|NN hla-drb111 overal estimate hla|NP difference|NN account|NN genetic predisposition|NN modern genetic method|NN association|NN study|NN reveal gene|NN hla|NP locus|NN modestly increase probability|NN Multiple sclerosis|Disease infectious agent|NN
microbe|NN propose trigger|NN Multiple sclerosis|Disease none confirm move early age|NN location|NN world|NN alter person|NN subsequent risk|NN Multiple sclerosis|Disease explanation|NN kind|NN infection|NN produce widespread microbe|NN rare relate disease|NN propose mechanism|NN include hygiene|NN hypothesis|NN prevalence|NN hypothesis|NN
hygiene|NN hypothesis|NN propose exposure|NN certain infectious agent|NN early life|NN protective disease|NN response|NN late encounter|NN agent|NN prevalence|NN hypothesis|NN propose disease|NN due infectious agent|NN common region|NN Multiple sclerosis|Disease common individual|NN cause ongo infection|NN symptom|NN
case|NN year|NN cause hygiene|NN hypothesis|NN receive support|NN prevalence|NN hypothesis|NN
evidence|NN virus|NN cause|NN include presence|NN oligoclonal band|NN brain|NN cerebrospinal fluid|NN people|NN Multiple sclerosis|Disease association|NN viruse|NN human demyelination|NN occurrence|NN demyelination|NN animal|NN cause viral infection|NN human herpe|NN viruse|NN candidate|NN group|NN viruse|NN
individual|NN infect epsteinbarr virus|NN reduce risk|NN get Multiple sclerosis|Disease infect young adult|NN greater risk|NN younger age|NN consider goe hygiene|NN hypothesis|NN non-infect probably experience hygienic upbring|NN believe contradiction|NN encounter|NN causative virus|NN relatively late life|NN trigger|NN disease|NN disease|NN relate include measle|NN mump|NN rubella|NN
smoke|NN show independent risk|NN factor|NN Multiple sclerosis|Disease stress|NN risk|NN factor|NN evidence|NN support weak association|NN occupational exposure|NN toxinsmainly|NN evaluate clear conclusion|NN reach study causal factor|NN study|NN show association|NN possible risk|NN factor|NN diet|NN hormone|NN intake|NN look evidence|NN relation|NN disease|NN sparse unpersuasive gout|NN occur expect lower level|NN uric acid|NN found people|NN Multiple sclerosis|Disease
led theory|NN uric acid|NN protective exact importance|NN remain unknown main article|NN pathophysiology|NN Multiple sclerosis|Disease Multiple sclerosis|Disease nerve|NN axon|NN myelin|NN sheath|NN
main characteristics|NN Multiple sclerosis|Disease formation|NN lesion|NN central nervous system|NN call plaque|NN inflammation|NN destruction|NN myelin|NN sheath|NN neuron|NN
feature|NN interact complex|NN fully understood manner|NN produce breakdown|NN nerve|NN tissue|NN turn|NN sign|NN symptom|NN disease|NN cholesterol|NN crystal|NN believe impair myelin|NN repair|NN aggravate inflammation|NN Multiple sclerosis|Disease believe immune-mediate disorder|NN develop interaction|NN individual|NN genetics|NN unidentify environmental cause|NN damage|NN believe cause part|NN attack|NN nervous system|NN person|NN immune system|NN demyelination|NN Multiple sclerosis|Disease
myelin|NN stain|NN area|NN lesion|NN appreciate
name|NN Multiple sclerosis|Disease refer scar|NN better known plaque|NN lesion|NN form|NN nervous system|NN
lesion|NN commonly affect white matter|NN optic|NN nerve|NN brain|NN stem|NN basal ganglia|NN spinal cord|NN white matter|NN tract|NN close lateral ventricle|NN function|NN white matter|NN cell|NN carry signal|NN grey matter|NN area|NN process|NN rest|NN body|NN
peripheral nervous system|NN rarely involve
specific Multiple sclerosis|Disease involve loss|NN oligodendrocyte|NN cell|NN responsible create maintain fatty layerknown|NN myelin|NN sheathwhich|NN help neuron|NN carry electrical signal|NN action|NN potential|NN result|NN thine|NN complete loss|NN myelin|NN disease|NN advance breakdown|NN axon|NN neuron|NN
myelin|NN lost neuron|NN longer effectively conduct electrical signal|NN repair|NN process|NN call take place|NN early phase|NN disease|NN oligodendrocyte|NN unable completely rebuild cell|NN myelin|NN sheath|NN repeate attack|NN lead successively effective remyelination|NN scar-like plaque|NN built damage axon|NN scar|NN origin|NN symptom|NN attack|NN magnetic resonance|NN image|NN mry|NN show new plaque|NN indicate number|NN lesion|NN brain|NN capable repair produce noticeable consequence|NN process|NN involve creation|NN lesion|NN abnormal increase|NN number|NN due|NN destruction|NN nearby neuron|NN number|NN lesion|NN pattern|NN describe
sign|NN disease|NN inflammation|NN
fit immunological explanation|NN inflammatory process|NN cause t|NP cell|NN kind|NN lymphocyte|NN play important role|NN body|NN t|NP cell|NN gain|NN entry|NN brain|NN disruption|NN bloodbrain barrier|NN
t|NP cell|NN recognize myelin|NN foreign attack|NN explain cell|NN call lymphocyte|NN
attack|NN myelin|NN start inflammatory process|NN trigger immune cell|NN release|NN soluble factor|NN cytokine|NN antibody|NN
further breakdown|NN blood-brain barrier|NN turn|NN cause number|NN damage effect|NN swell activation|NN macrophage|NN activation|NN cytokine|NN destructive protein|NN potentially reduce transmission|NN information|NN neuron|NN way|NN soluble factor|NN release stop intact neuron|NN
factor|NN lead enhance loss|NN myelin|NN cause axon|NN break completely barrier|NN
bloodbrain barrier|NN bbb|NN part|NN capillary system|NN prevent entry|NN t|NP cell|NN central nervous system|NN
become permeable type|NN cell|NN secondary infection|NN virus|NN bacteria|NN
repair typically infection|NN clear t|NP cell|NN remain trap brain|NN normal bbb|NN therefore gadolinium-enhance mry|NN use show breakdown|NN diagnosis|NN animation|NN show dissemination|NN brain|NN lesion|NN time|NN space|NN demonstrate monthly mry study|NN year|NN Multiple sclerosis|Disease seen mri|NP
Multiple sclerosis|Disease typically diagnose base present|NN sign|NN symptom|NN combination|NN support medical image|NN laboratory|NN test|NN difficult confirm especially early sign|NN symptom|NN similar medical problem|NN mcdonald|NP criteria|NN focus clinical laboratory|NN evidence|NN lesion|NN different time|NN different area|NN commonly use method|NN diagnosis|NN schumacher|NP poser|NP criteria|NN mostly historical significance|NN
clinical data|NN alone sufficient diagnosis|NN Multiple sclerosis|Disease individual|NN separate episode|NN neurological symptom|NN characteristic|NN disease|NN seek medical attention|NN attack|NN test|NN need diagnosis|NN
commonly use diagnostic tool|NN neuroimage analysis|NN cerebrospinal fluid|NN evoke potential|NN
magnetic resonance|NN image|NN brain|NN spine|NN show area|NN demyelination lesion|NN plaque|NN
administer intravenously contrast|NN agent|NN highlight active plaque|NN elimination|NN demonstrate existence|NN historical lesion|NN associate symptom|NN moment|NN evaluation|NN test|NN cerebrospinal fluid|NN obtain lumbar|NN puncture|NN provide evidence|NN chronic inflammation|NN central nervous system|NN
cerebrospinal fluid|NN test oligoclonal band|NN igg|NN electrophoresis|NN inflammation|NN marker|NN found 7585|NN people|NN Multiple sclerosis|Disease nervous system|NN Multiple sclerosis|Disease respond actively stimulation|NN optic|NN nerve|NN sensory nerve|NN due demyelination|NN pathway|NN
brain|NN response|NN examine use potential|NN
above criteria|NN allow non-invasive diagnosis|NN even state|NN definitive proof|NN autopsy|NN biopsy|NN lesion|NN typical Multiple sclerosis|Disease detect currently 2017|NN single test|NN biopsy|NN provide definitive diagnosis|NN disease|NN type|NN
phenotype|NN commonly term type|NN pattern|NN progression|NN describe
use past course|NN disease|NN attempt|NN predict future course|NN
important prognosis|NN treatment|NN decision|NN
currently united|NP states|NP national Multiple sclerosis|Disease society|NN Multiple sclerosis|Disease international federation|NN describe type|NN Multiple sclerosis|Disease revise
isolate syndrome|NN cis|NN Multiple sclerosis|Disease rr|NP Multiple sclerosis|Disease primary progressive Multiple sclerosis|Disease pp|NN Multiple sclerosis|Disease secondary progressive Multiple sclerosis|Disease sp|NN Multiple sclerosis|Disease
Multiple sclerosis|Disease characterize unpredictable relapse|NN follow period|NN month|NN year|NN relative quiet remission|NN new sign|NN disease|NN activity|NN
occur attack|NN resolve leave problem|NN attack|NN common longer person|NN disease|NN describe initial course|NN individual|NN Multiple sclerosis|Disease deficit|NN alway resolve attack|NN sometime refer benign Multiple sclerosis|Disease people|NN build degree|NN disability|NN long term|NN hand|NN term|NN malignant Multiple sclerosis|Disease use describe people|NN Multiple sclerosis|Disease reach significant level|NN disability|NN short period|NN relapsing-remit subtype|NN usually begin clinically isolate syndrome|NN cis|NN
cis|NN person|NN attack|NN suggestive demyelination|NN fulfil criteria|NN Multiple sclerosis|Disease person|NN experience cis|NN later develop Multiple sclerosis|Disease
primary progressive Multiple sclerosis|Disease occur approximately individual|NN remission|NN initial symptom|NN characterize progression|NN disability|NN onset|NN occasional minor remission|NN improvement|NN usual age|NN onset|NN primary progressive subtype|NN later relapsing-remit subtype|NN
similar age|NN secondary progressive usually begin Multiple sclerosis|Disease year|NN age|NN
secondary progressive Multiple sclerosis|Disease occur initial relapsing-remit|NN Multiple sclerosis|Disease eventually progressive neurologic decline|NN acute attack|NN definite period|NN remission|NN occasional relapse|NN minor remission|NN appear common length|NN time|NN disease|NN onset|NN conversion|NN relapsing-remit|NN secondary progressive Multiple sclerosis|Disease year|NN
unusual type|NN Multiple sclerosis|Disease describe include disease|NN concentric sclerosis|NN diffuse sclerosis|NN marburg|NN Multiple sclerosis|Disease
debate|NN Multiple sclerosis|Disease variant|NN different disease|NN Multiple sclerosis|Disease behave differently children|NN take time|NN reach progressive stage|NN nevertheless reach lower average|NN age|NN adult|NN usually management|NN main article|NN management|NN Multiple sclerosis|Disease
known cure|NN Multiple sclerosis|Disease therapy|NN proven helpful
primary aim|NN therapy|NN return function|NN attack|NN prevent new attack|NN prevent disability|NN
start medication|NN generally recommend people|NN attack|NN lesion|NN seen mri|NP
medical treatment|NN medication|NN use management|NN Multiple sclerosis|Disease adverse effect|NN
alternative treatment|NN pursue people|NN shortage|NN support evidence|NN
acute attack|NN
symptomatic attack|NN administration|NN high dose|NN intravenous corticosteroid|NN usual therapy|NN oral corticosteroid|NN seem similar efficacy|NN safety|NN profile|NN general effective short term|NN relieve symptom|NN corticosteroid treatment|NN appear significant impact|NN long-term recovery|NN consequence|NN severe attack|NN respond corticosteroid|NN treatable disease-modify treatment|NN Multiple sclerosis|Disease
disease-modify medication|NN approve regulatory agency|NN relapsing-remitting|NP Multiple sclerosis|Disease rr|NP Multiple sclerosis|Disease
interferon|NN interferon|NN acetate|NN fingolimod|NN dimethyl|NN ocrelizumab|NN
cost|NN effectiveness|NN 2012|NN unclear march|NP fda|NN approve humanize|NN monoclonal antibody|NN treatment|NN rr|NP Multiple sclerosis|Disease requirement|NN phase|NN clinical trial|NN
rr|NP Multiple sclerosis|Disease modestly effective decrease number|NN attack|NN interferon|NN acetate|NN first-line treatment|NN roughly equivalent reduce relapse|NN approximately early-initiate|NN long-term therapy|NN safe improve outcome|NN reduce relapse|NN rate|NN first-line agent|NN due issue|NN adverse effect|NN second-line agent|NN reserve respond treatment|NN severe disease|NN use|NN limit severe adverse effect|NN third-line option|NN respond medication|NN treatment|NN clinically isolate syndrome|NN cis|NN interferon|NN decrease chance|NN progress clinical Multiple sclerosis|Disease efficacy|NN interferon|NN acetate|NN children|NN estimate roughly equivalent adult|NN role|NN newer agent|NN teriflunomide|NN dimethyl|NN entirely clear
rituximab|NN widely use treat rr|NP Multiple sclerosis|Disease progressive Multiple sclerosis|Disease
rituximab|NN widely use treat progressive primary Multiple sclerosis|Disease march|NP fda|NN approve ocrelizumab treatment|NN primary progressive Multiple sclerosis|Disease drug|NN gain approval|NN requirement|NN phase|NN clinical trial|NN
medication|NN mitoxantrone|NN approve secondary progressive Multiple sclerosis|Disease population|NN tentative evidence|NN support|NN moderately slow progression|NN disease|NN decrease rate|NN relapse|NN year|NN adverse effect|NN zone|NN injection|NN acetate|NN
disease-modify treatment|NN adverse effect|NN
common irritation|NN injection|NN site|NN acetate|NN interferon|NN subcutaneous injection|NN intramuscular injection|NN time|NN visible dent|NN injection|NN site|NN due local destruction|NN fat tissue|NN known lipoatrophy|NN develop produce flu-like symptom|NN people|NN take experience|NN post-injection reaction|NN flush|NN chest|NN tightness|NN heart|NN palpitation|NN anxiety|NN usually last minute|NN dangerous common liver|NN damage|NN systolic dysfunction|NN infertility|NN acute myeloid|NN progressive multifocal|NN occure natalizumab|NN occure people|NN treate
give rise|NN hypertension|NN slow heart|NN rate|NN elevate liver|NN enzyme|NN reduction|NN lymphocyte|NN level|NN evidence|NN support short-term safety|NN teriflunomide|NN common side|NN effect|NN headache|NN fatigue|NN nausea|NN hair|NN loss|NN limb|NN pain|NN report|NN liver|NN failure|NN pml|NN use|NN dangerous fetal development|NN common side|NN effect|NN dimethyl|NN fumarate|NN flush gastrointestinal problem|NN dimethyl|NN fumarate|NN lead reduction|NN white blood|NN cell|NN count|NN report case|NN opportunistic infection|NN trial|NN associate symptom|NN
medication|NN neurorehabilitation|NN show improve symptom|NN change|NN course|NN disease|NN symptom|NN good response|NN medication|NN unstable bladder|NN spasticity|NN little change neurologic problem|NN multidisciplinary approach|NN important improve quality|NN life|NN difficult specify core|NN team|NN health|NN service|NN need different point|NN time|NN rehabilitation|NN program|NN increase|NN activity|NN participation|NN people|NN Multiple sclerosis|Disease influence impairment|NN level|NN limit evidence|NN overal efficacy|NN individual therapeutic discipline|NN good evidence|NN specific approache|NN exercise|NN psychological therapy|NN effective cognitive behavioral|NN therapy|NN show moderately effective reduce Multiple sclerosis|Disease fatigue|NN alternative|NN treatment|NN
people|NN Multiple sclerosis|Disease use complementary alternative medicine|NN percentage|NN vary alternative medicine|NN define evidence|NN effectiveness|NN treatment|NN case|NN weak absent treatment|NN unproven benefit|NN use people|NN Multiple sclerosis|Disease include dietary supplementation|NN regimen|NN vitamin|NN d|NP relaxation|NN technique|NN yoga|NN herbal medicine|NN medical cannabis|NN oxygen|NN therapy|NN reflexology|NN acupuncture|NN mindfulness|NN characteristics|NN user|NN frequently women|NN Multiple sclerosis|Disease longer time|NN tend disable lower level|NN satisfaction|NN conventional healthcare|NN life|NN year|NN Multiple sclerosis|Disease inhabitant|NN 32-68|NN 77-88|NN 119-119|NN 470-910|NN
expect future|NN course|NN disease|NN depend subtype|NN disease|NN individual|NN sex|NN age|NN initial symptom|NN degree|NN disability|NN person|NN female sex|NN subtype|NN optic|NN sensory symptom|NN onset|NN attack|NN initial year|NN especially early age|NN onset|NN associate better course|NN
average life|NN expectancy|NN year|NN start|NN disease|NN year|NN unaffect people|NN people|NN Multiple sclerosis|Disease reach|NN decade|NN life|NN nevertheless death|NN directly relate consequence|NN disease|NN suicide|NN common infection|NN complication|NN especially dangerous disable people|NN lose ability|NN walk death|NN capable independent walk|NN year|NN onset|NN update|NN
epidemiology|NN death|NN Multiple sclerosis|Disease person|NN 2012|NP
Multiple sclerosis|Disease common autoimmune|NN disorder|NN central nervous system|NN number|NN people|NN Multiple sclerosis|Disease approximately globally rate|NN vary widely different region|NN estimate result 18000 death|NN year|NN africa|NP rate|NN south|NP east|NP asia|NP americas|NP europe|NP rate|NN surpass certain population|NN northern european descent|NN number|NN new case|NN develop year|NN
rate|NN Multiple sclerosis|Disease appear increase explain simply better diagnosis|NN study|NN populational|NN geographical pattern|NN common led number|NN theory|NN cause|NN
Multiple sclerosis|Disease usually appear adult|NN late early rarely start childhood|NN year|NN age|NN primary progressive subtype|NN common people|NN similar autoimmune|NN disorder|NN disease|NN common women|NN trend|NN increase globally time|NN common women|NN men|NN children|NN even common female|NN male|NN people|NN affect male|NN female|NN equally history|NN medical discovery|NN detail|NN draw|NN Multiple sclerosis|Disease lesion|NN brain|NN stem|NN spinal cord|NN
robert|NP carswell|NP british professor|NN pathology|NN jean|NP cruveilhier|NP french professor|NN anatomy|NN describe illustrate disease|NN clinical detail|NN identify separate disease|NN specifically carswell|NP describe injury|NN found remarkable lesion|NN spinal cord|NN accompany atrophy|NN microscope|NN swiss pathologist|NN georg|NP eduard|NP 18361908|NP note inflammation-associate lesion|NN distribute blood|NN vessel|NN
french neurologist|NN 18251893|NN person|NN recognize Multiple sclerosis|Disease distinct disease|NN summarize previous report|NN ad clinical pathological observation|NN call disease|NN en plaque|NN
attempt|NN establish set|NN diagnostic criteria|NN due charcot
publish known charcot triad|NN consist intention|NN tremor|NN telegraphic speech|NN scan|NN speech|NN observe cognition|NN change|NN describe patient|NN mark enfeeblement|NN memory|NN conception|NN form slowly
diagnosis|NN base triad|NN clinical observation|NN schumacher|NP made attempt|NN standardize criteria|NN introduce fundamental requirement|NN dissemination|NN lesion|NN time|NN space|NN sign|NN symptom|NN explain better disease|NN process|NN requirement|NN later inherit poser criteria|NN mcdonald|NP criteria|NN version|NN currently use|NN
century|NN theory|NN cause|NN pathogenesis|NN develop effective treatment|NN began appear begine|NN century|NN refinement|NN concept|NN taken place|NN
revision|NN mcdonald|NP criteria|NN allow diagnosis|NN Multiple sclerosis|Disease prove lesion|NN cis|NN subsequently year|NN later 2013 revision|NN phenotype|NN disease|NN course|NN force consider cis|NN phenotype|NN Multiple sclerosis|Disease make obsolete expression|NN conversion|NN cis|NN Multiple sclerosis|Disease historical case|NN photographic study|NN locomotion|NN female|NN Multiple sclerosis|Disease walk|NN difficulty|NN create
historical account|NN people|NN probably Multiple sclerosis|Disease live shortly disease|NN describe
young woman|NN call live iceland|NP suddenly lost vision|NN mobility|NN pray saint|NN recover day|NN
saint|NP lidwina|NP schiedam|NP dutch nun|NN clearly identifiable people|NN Multiple sclerosis|Disease
age|NN death|NN intermittent pain|NN weakness|NN leg|NN vision|NN typical Multiple sclerosis|Disease case|NN led proposal|NN vike|NN gene|NN hypothesis|NN dissemination|NN disease|NN
augustus|NP frederick|NP son|NN prince|NP augustus|NP frederick|NP duke|NN sussex|NP lady|NP augusta|NP murray|NP grandson|NN george|NP united|NP kingdom|NP certainly Multiple sclerosis|Disease
left detail diary|NN describe year|NN live disease|NN
diary|NN began end remain unknown
symptom|NN began age|NN sudden transient visual loss|NN fugax|NN funeral|NN friend|NN
disease|NN develop weakness|NN leg|NN clumsiness|NN hand|NN numbness|NN dizziness|NN bladder|NN disturbance|NN dysfunction|NN
began use wheelchair|NN
illness|NN kept optimistic view|NN life|NN early account|NN Multiple sclerosis|Disease kept british diarist|NN w|NN
nom-de-plume|NN bruce|NP frederick|NP cummings|NP maintain detail log|NN diagnosis|NN struggle|NN diary|NN publish journal|NN disappoint man|NN research|NN main article|NN Multiple sclerosis|Disease research|NN journal|NN formerly known Multiple sclerosis|Disease see Multiple sclerosis|Disease journal|NN
chemical structure|NN
ongo research|NN look effective convenient tolerable treatment|NN Multiple sclerosis|Disease creation|NN therapy|NN progressive subtype|NN strategy|NN effective symptomatic treatment|NN
2000|NN 2010|NN approval|NN oral drug|NN expect gain popularity|NN frequency|NN use|NN oral drug|NN investigation|NN laquinimod|NN estriol|NN
announce august|NP phase|NN trial|NN mix result|NN previous similarly study|NN aim improve efficacy|NN ease|NN use|NN exist therapy|NN occure
include use|NN new preparation|NN pegylate version|NN
hope give frequent dose|NN similar effect|NN female sex|NN hormone|NN found high concentration|NN late pregnancy|NN identify candidate|NN therapy|NN women|NN Multiple sclerosis|Disease progress phase|NN trial|NN request|NN approval|NN beta-1a|NN expect
monoclonal antibody|NN raise high level|NN interest|NN
alemtuzumab|NN monoclonal antibody|NN ocrelizumab|NN show benefit|NN study|NN potential treatment|NN fda|NN approve ocrelizumab relapse|NN primary Multiple sclerosis|Disease march|NP use|NN accompany appearance|NN potentially dangerous adverse effect|NN important opportunistic infection|NN relate investigation|NN development|NN test|NN jc|NP virus|NN antibody|NN help determine greater risk|NN develop progressive multifocal|NN take natalizumab|NN monoclonal antibody|NN probably role|NN treatment|NN disease|NN future|NN believe small risk|NN associate
research|NN strategy|NN evaluate combine effectiveness|NN drug|NN main rationale|NN use number|NN medication|NN Multiple sclerosis|Disease involve treatment|NN target|NN different mechanism|NN therefore use|NN necessarily exclusive synergy|NN drug|NN improve effect|NN possible drawback|NN block|NN action|NN worsen side-effect|NN trial|NN combine therapy|NN none show positive result|NN consider useful treatment|NN Multiple sclerosis|Disease
research|NN neuroprotection|NN regenerative treatment|NN stem|NN cell|NN therapy|NN high importance|NN early stage|NN likewise effective treatment|NN progressive variant|NN disease|NN
newest drug|NN well development|NN probably go evaluate therapy|NN pp|NN Multiple sclerosis|Disease sp|NN Multiple sclerosis|Disease
Multiple sclerosis|Disease clinically define entity|NN atypical presentation|NN
auto-antibody|NN found atypical Multiple sclerosis|Disease case|NN give birth|NN separate disease|NN family|NN restrict previously wider concept|NN Multiple sclerosis|Disease
anti-aqp4 autoantibody|NN found optica|NN previously consider Multiple sclerosis|Disease variant|NN
whole spectrum|NN disease|NN name spectrum|NN disease|NN anti-aqp4 disease|NN accept
later found case|NN Multiple sclerosis|Disease present autoantibody|NN mainly overlap marburg variant|NN
autoantibody|NN found present adem|NN spectrum|NN separate disease|NN consider
moment|NN name inconsistently different author|NN normally similar demyelinate disease|NN
finally kind|NN auto-antibody|NN accept
anti-neurofascin|NN damage|NN ranvier node|NN neurone|NN
antibody|NN relate peripheral nervous demyelination|NN found chronic progressive pp|NN Multiple sclerosis|Disease combine central peripheral demyelination|NN consider atypical Multiple sclerosis|Disease presentation|NN
beside autoantibody|NN found different pattern|NN demyelination|NN report Multiple sclerosis|Disease open|NN door|NN consider Multiple sclerosis|Disease heterogeneous disease|NN disease|NN mry brain|NN scan|NN produce use gradient-echo phase|NN sequence|NN show iron|NN deposit|NN white matter|NN lesion|NN green box|NN middle|NN image|NN enhance mark red arrow|NN corner|NN
diagnostic criteria|NN expect change near future|NN work|NN develop help|NN diagnosis|NN prediction|NN disease|NN progression|NN ongo new diagnostic method|NN investigate include work|NN anti-myelin antibody|NN study|NN serum|NN cerebrospinal fluid|NN yield reliably positive result|NN
current time|NN laboratory|NN investigation|NN predict prognosis|NN
promise approache|NN propose nitric oxide|NN nitric oxide|NN synthase|NN fetuin-a disease|NN progression|NN result|NN degeneration|NN neuron|NN role|NN protein|NN show loss|NN nerve|NN tissue|NN tau|NN investigation|NN effect|NN include look distinguish respond medication|NN
improvement|NN neuroimage technique|NN positron|NN emission|NN tomography|NN pet|NN magnetic resonance|NN image|NN mry|NN carry promise|NN better diagnosis|NN prognosis|NN prediction|NN effect|NN improvement|NN daily medical practice|NN take decade|NN mri|NP technique|NN show usefulness|NN research|NN set|NN introduce clinical practice|NN recovery|NN sequence|NN transfer|NN diffusion|NN tensor|NN functional magnetic resonance|NN image|NN technique|NN specific disease|NN exist lack standardization|NN acquisition|NN protocol|NN creation|NN normative value|NN technique|NN development|NN include contrast|NN agent|NN capable measure level|NN peripheral macrophage|NN inflammation|NN neuronal dysfunction|NN technique|NN measure|NN iron|NN deposition|NN serve determine role|NN feature|NN Multiple sclerosis|Disease cerebral perfusion|NN similarly new pet|NN serve marker|NN alter process|NN brain|NN inflammation|NN cortical pathology|NN apoptosis|NN antibiody|NN kir41 potassium|NN channel|NN relate Multiple sclerosis|Disease chronic cerebrospinal venous insufficiency|NN main article|NN chronic cerebrospinal venous insufficiency|NN
vascular surgeon|NN paolo|NP zamboni|NP suggest Multiple sclerosis|Disease involve narrow|NN vein|NN drain brain|NN refer chronic cerebrospinal venous insufficiency|NN
found patient|NN Multiple sclerosis|Disease study|NN perform surgical procedure|NN later call media|NN liberation|NN procedure|NN correct claim participant|NN improve theory|NN receive significant attention|NN media|NN Multiple sclerosis|Disease especially canada|NP concern|NN raise research|NN neither blind control assumption|NN underly cause|NN disease|NN back known data|NN further study|NN found similar relationship|NN found strong raise|NN serious objection|NN hypothesis|NN liberation|NN procedure|NN criticize result serious complication|NN death|NN unproven benefit|NN 2013|NN recommend treatment|NN Multiple sclerosis|Disease additional research|NN investigate ccsvy hypothesis|NN update|NN see
list|NN Multiple sclerosis|Disease organization|NN list|NN people|NN Multiple sclerosis|Disease
